Skip to content
CD274 molecule
ProteinQ21100639· pop 10· linked from 457 articles

CD274 molecule

Sign in to save

Also known as B7 homolog 1, B7-H1 Antigen, PDCD1 ligand 1, B7-H1, programmed cell death 1 ligand 1, CD274, CD274 antigen, PD-L1

Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1) is a protein that in humans is encoded by the CD274 gene.

Protein · UniProt

Programmed cell death 1 ligand 1

Gene
CD274
Organism
Homo sapiens (Human)
Length
290 aa
Molecular mass
33,275 Da
Evidence
1: Evidence at protein level

Plays a critical role in induction and maintenance of immune tolerance to self (PubMed:11015443, PubMed:28813410, PubMed:28813417, PubMed:31399419). As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response (PubMed:11015443, PubMed:28813410, PubMed:28813417, PubMed:36727298). Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (PubMed:10581077). Can also act as a transcription coactivator: in response to hypoxia, translocates into the nucleus via…

3D-structureAdaptive immunityAlternative splicingCell membraneDiabetes mellitusDisulfide bondEndosomeGlycoprotein
View on UniProt →

Swiss-Prot (reviewed) · via UniProt

~11 min read

Article

15 sections
Contents
  • History
  • Binding
  • Signaling
  • Regulation
  • By interferons
  • On macrophages and monocytes
  • Role of microRNAs
  • Epigenetic regulation
  • Clinical significance
  • Cancer
  • ''Listeria monocytogenes''
  • Autoimmunity
  • See also
  • References
  • External links

Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1) is a protein that in humans is encoded by the CD274 gene.

Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the adaptive arm of immune systems during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. Normally the adaptive immune system reacts to antigens that are associated with immune system activation by exogenous or endogenous danger signals. In turn, clonal expansion of antigen-specific CD8+ T cells and/or CD4+ helper cells is propagated. The binding of PD-L1 to the inhibitory checkpoint molecule PD-1 transmits an inhibitory signal based on interaction with phosphatases (SHP-1 or SHP-2) via Immunoreceptor Tyrosine-Based Switch Motif (ITSM). This reduces the proliferation of antigen-specific T-cells in lymph nodes, while simultaneously reducing apoptosis in regulatory T cells (anti-inflammatory, suppressive T cells) – further mediated by a lower regulation of the gene Bcl-2. PD-L1 is expressed on both hematopoietic and nonhematopoietic cells in tissues. However, the exact roles of PD-L1 on hematopoietic versus nonhematopoietic cells in modulating immune responses are unclear.

Gallery (3)

Available in 10 languages

via Wikidata sitelinks · CC0

Connections

Categories